During the past decade, Nara Medical University Hospital conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 13 clinical trials were completed, i.e. on average, 35.1% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 12 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nara Medical University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Merck Sharp & Dohme LLC" with 5 trials sponsored, "Pfizer" with 4 trials sponsored, "Incyte Corporation" with 3 trials sponsored and "Aichi Cancer Center" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nara Medical University Hospital" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "EPS Corporation" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Nara Medical University Hospital" are "Prostatic Neoplasms" (5 trials), "Hemophilia B" (3 trials), "Carcinoma, Renal Cell" (2 trials), "Colitis, Ulcerative" (2 trials) and "Head and Neck Cancer" (2 trials). Many other conditions were trialed in "Nara Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Nara Medical University Hospital" are "Drug" (38 trials), "Biological" (10 trials), "Device" (4 trials), "Other" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Pembrolizumab" (7 trials), "Guselkumab" (4 trials), "Enzalutamide" (3 trials) and "Epacadostat" (3 trials). Other intervention names were less common.

The vast majority of trials in "Nara Medical University Hospital" are 36 trials for "All" genders, 9 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Nara Medical University Hospital". undefined are not yet recruiting, 10 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Nara Medical University Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Nara Medical University Hospital, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".